1 August 2002
Multiple Sclerosis, vol. 8, no. 4, pp. 289-294(6)
Kaufman M; Gaydos CA; Sriram S; Boman J; Tondella ML; Norton HJ
 Carolinas Medical Center, ROB #410, PO Box 32861, Charlotte, North Carolina 28232-2861, USA  Johns Hopkins University, Division of Infectious Diseases, 1159 Ross Bldg., 720 Rutland Ave., Baltimore, Maryland 21205, USA  Department of Neurology, Vanderbilt University Medical Center, Vanderbilt Stallworth Rehab, 2201 Capers Ave., Room 1222, Nashville, Tennessee 37212-3164, USA  Department of Virology, University of Umeå, SE-901 85 Umeå, Sweden  Center for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, Georgia 30333, USA
Cerebrospinal fluid samples from controls and patients with multiple sclerosis (MS) were split and sent to laboratories with different experiences for the detection of Chlamydia pneumoniae by polymerase chain reaction.
Vanderbilt investigators identified C. pneumoniae in the majority of patients with MS and uncommonly in controls.
Laboratories at Johns Hopkins University, University of Umeå, and the Centers for Disease Control and Prevention did not identify C. pneumoniae in any of the samples.
of C. pneumoniae detection in the same samples from patients with MS highlight
the need to exchange detection techniques among laboratories involved in
© 2002 ingenta